Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Network
-
Potentiation of Immune Checkpoint Blockade by Inhibition of Epoxyeicosatrienoic Acid Driven Tumor Respiration
Potter, D. A., Farrar, M. A., Schumacher, R. J. & Schwertfeger, K.
3/15/19 → 3/14/23
Project: Research project
-
An Open Label Phase 2 Study of MLN0128 in Combination wi
MILLENNIUM PHARMACEUTICALS, INC.
1/1/17 → 1/30/23
Project: Research project
-
The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
Jenkins, J. A., Marmor, S., Hui, J., Beckwith, H., Blaes, A. H., Potter, D. A. & Tuttle, T. M., Jan 2022, In: Breast Cancer Research and Treatment. 191, 2, p. 401-407 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
A Neoadjuvant Chemotherapy Trial for Early Breast Cancer is Impacted by COVID-19: Addressing Vaccination and Cancer Trials Through Education, Equity, and Outcomes
Potter, D. A., Thomas, A. & Rugo, H. S., Aug 15 2021, In: Clinical Cancer Research. 27, 16, p. 4486-4490 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis
Wang, H., Zhang, S., Yee, D., Basu, S., Beckwith, H. C., Potter, D. A. & Blaes, A. H., May 2021, In: Breast Cancer. 28, 3, p. 618-629 12 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Recent advances in neoadjuvant therapy for breast cancer
Potter, D. A., Herrera-Ponzanelli, C. A., Hinojosa, D., Castillo, R., Hernandez-Cruz, I., Arrieta, V. A., Franklin, M. J. & Yee, D., Jan 4 2021, In: Faculty reviews. 10, p. 2Research output: Contribution to journal › Review article › peer-review
Open Access -
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor–Positive/HER2-Negative Advanced or Metastatic Breast Cancer
Lim, B., Potter, D. A., Salkeni, M. A., Silverman, P., Haddad, T. C., Forget, F., Awada, A., Canon, J., Danso, M., Lortholary, A., Bourgeois, H., Tan-chiu, E., Vincent, S., Bahamon, B., Galinsky, K. J., Patel, C., Neuwirth, R., Leonard, E. J. & Diamond, J. R., Jun 15 2021, In: Clinical Cancer Research. 27, 12, p. 3329-3338 10 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations